Clinical Catalyst Radar for Biotech
Pricing
Pay per usage
Clinical Catalyst Radar for Biotech
For each biotech company, correlates clinical pipeline progress (ClinicalTrials.gov) and research momentum (PubMed) with open-market insider buying (SEC Form 4), scores convergence 0 to 100, and tiers companies catalyst, clinical lead, insider lead, or watch. An advancing asset plus insiders buying.